S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
Warren Buffett uses his annual letter to warn about Wall Street and recount Berkshire's successes
The perfect AI stock under $10 (Ad)
A collection of the insights Warren Buffett offered in his annual letter Saturday
West Africa's ECOWAS bloc says it's lifting sanctions imposed on Niger over last year’s coup in a new push for dialogue
The perfect AI stock under $10 (Ad)
Macron booed by French farmers who blame him for not doing enough to support agriculture
MILAN FASHION PHOTOS: Ferragamo, Dolce&Gabbana conceal and reveal, balance transparency with cover
The Retirement of Your Dreams Awaits You… (Ad)
Tax-free status of movie, music and games traded online is on table as WTO nations meet in Abu Dhabi
Corruption scandals cast a shadow over Portugal’s early general election and may favor populists
S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
Warren Buffett uses his annual letter to warn about Wall Street and recount Berkshire's successes
The perfect AI stock under $10 (Ad)
A collection of the insights Warren Buffett offered in his annual letter Saturday
West Africa's ECOWAS bloc says it's lifting sanctions imposed on Niger over last year’s coup in a new push for dialogue
The perfect AI stock under $10 (Ad)
Macron booed by French farmers who blame him for not doing enough to support agriculture
MILAN FASHION PHOTOS: Ferragamo, Dolce&Gabbana conceal and reveal, balance transparency with cover
The Retirement of Your Dreams Awaits You… (Ad)
Tax-free status of movie, music and games traded online is on table as WTO nations meet in Abu Dhabi
Corruption scandals cast a shadow over Portugal’s early general election and may favor populists
S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
Warren Buffett uses his annual letter to warn about Wall Street and recount Berkshire's successes
The perfect AI stock under $10 (Ad)
A collection of the insights Warren Buffett offered in his annual letter Saturday
West Africa's ECOWAS bloc says it's lifting sanctions imposed on Niger over last year’s coup in a new push for dialogue
The perfect AI stock under $10 (Ad)
Macron booed by French farmers who blame him for not doing enough to support agriculture
MILAN FASHION PHOTOS: Ferragamo, Dolce&Gabbana conceal and reveal, balance transparency with cover
The Retirement of Your Dreams Awaits You… (Ad)
Tax-free status of movie, music and games traded online is on table as WTO nations meet in Abu Dhabi
Corruption scandals cast a shadow over Portugal’s early general election and may favor populists
S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
Warren Buffett uses his annual letter to warn about Wall Street and recount Berkshire's successes
The perfect AI stock under $10 (Ad)
A collection of the insights Warren Buffett offered in his annual letter Saturday
West Africa's ECOWAS bloc says it's lifting sanctions imposed on Niger over last year’s coup in a new push for dialogue
The perfect AI stock under $10 (Ad)
Macron booed by French farmers who blame him for not doing enough to support agriculture
MILAN FASHION PHOTOS: Ferragamo, Dolce&Gabbana conceal and reveal, balance transparency with cover
The Retirement of Your Dreams Awaits You… (Ad)
Tax-free status of movie, music and games traded online is on table as WTO nations meet in Abu Dhabi
Corruption scandals cast a shadow over Portugal’s early general election and may favor populists

Inventiva (IVA) Stock Forecast & Price Target

$3.42
+0.02 (+0.59%)
(As of 02/23/2024 ET)

Inventiva Consensus Analyst Rating and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Analysts' Consensus Rating

Buy
Based on 8 Analyst Ratings

Analysts' Consensus Price Target

$16.00
367.84% Upside
High Forecast$25.00
Average Forecast$16.00
Low Forecast$11.00
TypeCurrent Forecast
2/25/23 to 2/25/24
1 Month Ago
1/26/23 to 1/26/24
3 Months Ago
11/27/22 to 11/27/23
1 Year Ago
2/25/22 to 2/25/23
Consensus Rating
Buy
Buy
Buy
Hold
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
8 Buy rating(s)
8 Buy rating(s)
7 Buy rating(s)
1 Buy rating(s)
Hold
0 Hold rating(s)
0 Hold rating(s)
0 Hold rating(s)
0 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
1 Sell rating(s)
Consensus Price Target$16.00$14.20$16.40$36.00
Predicted Upside367.84% Upside263.36% Upside329.32% Upside823.08% Upside
Get Inventiva Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for IVA and its competitors with MarketBeat's FREE daily newsletter.


IVA Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

IVA Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Inventiva Stock vs. The Competition

TypeInventivaMedical CompaniesS&P 500
Consensus Rating Score
3.00
2.68
2.48
Consensus RatingBuyModerate BuyHold
Predicted Upside367.84% Upside1,898.08% Upside7.54% Upside
News Sentiment RatingPositive News
Neutral News
Positive News

Recent Analyst Ratings and Stock Forecasts

DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
2/16/2024Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetBuy ➝ Buy$27.00 ➝ $25.00+657.57%
1/5/2024Lifesci Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
R. Katkhuda
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform
12/21/2023HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetBuy ➝ Buy$36.00 ➝ $24.00+458.14%
10/27/2023Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageBuy$12.00+215.79%
9/21/2023Roth Mkm
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingBuy ➝ Buy$11.00+165.70%
9/1/2023Guggenheim
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingBuy ➝ Buy$12.00+227.87%
5/19/2023Societe Generale
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeSell ➝ Buy

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Sunday at 08:24 AM ET.












IVA Price Target - Frequently Asked Questions

What is Inventiva's consensus rating and price target?

According to the issued ratings of 8 analysts in the last year, the consensus rating for Inventiva stock is Buy based on the current 8 buy ratings for IVA. The average twelve-month price prediction for Inventiva is $16.00 with a high price target of $25.00 and a low price target of $11.00. Learn more on IVA's analyst rating history.

Do Wall Street analysts like Inventiva more than its competitors?

Analysts like Inventiva more than other Medical companies. The consensus rating for Inventiva is Buy while the average consensus rating for medical companies is Moderate Buy. Learn more on how IVA compares to other companies.

Does Inventiva's stock price have much upside?

According to analysts, Inventiva's stock has a predicted upside of 320.32% based on their 12-month stock forecasts.

What analysts cover Inventiva?

Inventiva has been rated by HC Wainwright, Lifesci Capital, and Stifel Nicolaus in the past 90 days.


Stock Ratings Reports and Tools

This page (NASDAQ:IVA) was last updated on 2/25/2024 by MarketBeat.com Staff